The Future of Vascular Treatments: Exploring the Drug-Eluting Balloon Market

The Drug-Eluting Balloon Market is undergoing significant transformation, influenced by technological breakthroughs, evolving clinical practices, and heightened demand for minimally invasive vascular treatment solutions. Drug-eluting balloons (DEBs) are gaining traction as a promising alternative to stents in specific clinical scenarios, particularly in the treatment of peripheral artery disease (PAD) and in-stent restenosis (ISR).

Read More: - https://www.theinsightpartners.com/reports/drug-eluting-balloons-market